Unither
FranceWho owns Unither?
Unither is a French Pharma company, currently owned by IK Partners since 2023 and 3 other investors. It changed hands in 2023, when Ardian sold.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
- ·Co-held by Picardie Investissement Gestion, NiXEN, Parquest Capital and IK Partners since 1993.
- ·Average hold across 2 realized cycles: 6 years.
- ·5 distinct PE sponsors across ownership cycles.
Ownership history
6 ownership periods · co-invest detected
NiXEN exited Unither in 2019 via Trade Sale after 5 years.
Ardian sold Unither to IK Partners / GIC / Keensight / Parquest / management in 2023 after 6 years.
More from IK Partnership Fund II
Other portfolio companies in the same fund.
UK
Netherlands
GermanyMore PE-backed in Pharma
Comparable pharma deals from other GPs.
US
SpainQuestions
Who owns Unither?
Unither is currently owned by IK Partners, NiXEN and 2 others, through IK Partnership Fund II, since 2023.
When did IK Partners and 3 others acquire Unither?
IK Partners and 3 others acquired Unither in 2023.
Who did Unither sell to?
Ardian sold Unither to IK Partners / GIC / Keensight / Parquest / management in 2023 (Secondary).
Who has owned Unither over time?
Unither has been through 6 private-equity ownership periods: Picardie Investissement Gestion · via Picardie Investissement · 1993–2019; NiXEN · via NiXEN II · 2014–2019 · (Trade Sale); Ardian · via Ardian Buyout Fund VII · 2017–2023 · sold to IK Partners / GIC / Keensight / Parquest / management · (Secondary); NiXEN · via NiXEN II · since 2022; Parquest Capital · via Parquest Capital 2 · since 2022; IK Partners · via IK Partnership Fund II · since 2023.